BLOG

NK Cell Therapy After Cancer Treatment: Questions to Ask About Recurrence Prevention

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Finishing surgery, chemotherapy or radiation can bring relief, but it often brings a new worry as well: what happens next, and could the cancer return? Some patients start looking for ways to support their health during this follow-up period. One option they come across is NK cell therapy, an immune cell therapy that uses a patient’s own natural killer cells. This article explains what “recurrence prevention” can realistically mean in this context, where the limits are, and what to ask before you decide. It is general information, not medical advice.

The short answer

At Grand Green Osaka Umekita Clinic, NK cell therapy can be received with the aim of supporting immune function and helping prevent recurrence after cancer treatment. That wording describes an aim, not a promise. No immune cell therapy can guarantee that cancer will not come back, and it is not a replacement for standard follow-up care, scheduled scans, or the advice of your oncologist. Whether it is suitable for you is a decision that requires a medical consultation.

It is also important to know that NK cell therapy is offered as a self-pay (non-insured) treatment in Japan. Costs, risks, possible side effects and eligibility must all be confirmed with a doctor before you start.

Why recurrence worries linger after treatment

Standard treatments are designed to remove or shrink tumors that can be detected. Even so, small numbers of abnormal cells may remain in some patients, and follow-up exams exist precisely to watch for changes. This uncertainty is a normal part of life after cancer, and many people want to do something proactive.

Your immune system plays a role in this picture. Healthy people are thought to produce abnormal cells regularly, and immune cells, including NK cells, help find and remove them through a mechanism called immune surveillance. NK cell activity is known to decline with age, with stress, and with the effects of cancer itself. The idea behind NK cell therapy is to return a larger number of more active NK cells to the body, with the aim of reinforcing weakened immune function. The strength of the evidence for any specific cancer type varies, so it is reasonable to ask your doctor what is and is not known.

How NK cell therapy works in brief

NK cells are a type of lymphocyte that can recognize and attack abnormal cells without waiting for instructions from other immune cells. In the therapy, a standard blood sample is taken, and the NK cells are activated and expanded at a specialized, licensed cell processing facility. They are then returned to your body by intravenous infusion.

Because the cells come from your own body (autologous cells), the risk of rejection is considered low, and serious side effects have rarely been reported. Temporary fever or fatigue can occur. Treatment involves a blood draw and an infusion without hospitalization, so many patients can continue daily life during the course. These are general features of the approach, and your own situation may differ.

What this therapy does not do

Being clear about limits helps you avoid disappointment and poor decisions. NK cell therapy does not cure cancer, and it does not make follow-up care unnecessary. It should not be seen as an alternative to surgery, chemotherapy, radiation therapy or other standard treatments recommended by your oncologist. Results differ between individuals, and some people may not experience the benefit they hoped for.

Be cautious about any source that promises dramatic outcomes, relies mainly on personal testimonials, or discourages you from continuing recommended hospital care. A trustworthy discussion will include uncertainty, costs and the possibility that the therapy does not help.

Questions to ask before you decide

A consultation is most useful when you arrive prepared. Consider raising the following points with the clinic and with your own oncologist:

  • Are my cancer type and current stage a reasonable fit for this therapy, and what is known about it for situations like mine?
  • How does the timing relate to my surgery, chemotherapy or radiation, and does it need to be adjusted?
  • What is the total cost, how many sessions are usually planned, and over what period?
  • What side effects and risks should I expect, and what happens if I feel unwell after returning home?
  • How will my results be monitored, and who shares information with my home hospital?
  • Under which legal framework is the treatment provided, and how are cells processed and checked?

In Japan, NK cell therapy is provided under the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be submitted to and accepted by the authorities. Asking how this applies to the clinic you are considering is a sensible step.

Working alongside your oncologist

The therapy is not generally considered to interfere with surgery, chemotherapy or radiation, so it can be considered alongside them, and the clinic can coordinate with the medical institution providing your standard treatment. In practice, this means you should keep your regular appointments, bring your records, and tell every doctor involved about the treatments you receive. Open communication lets each physician judge your overall plan safely.

If you are traveling from overseas, think about how follow-up will work once you return home, and ask whether translated summaries can be shared with your local doctor.

Consulting in Osaka and next steps

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka and offers information pages for international patients, including an English page, so that you can review the process in your own language before contacting the clinic. A good first step is to gather your diagnosis, treatment history and recent test results, write down your questions, and request a consultation. The doctor will assess whether NK cell therapy is appropriate and explain fees, schedule, risks and side effects in detail.

To sum up, NK cell therapy may be considered after cancer treatment as a way to support immune function, but it cannot guarantee that cancer will not return. Use it, if at all, as an addition to standard follow-up and not a substitute, and make the decision together with your doctors after a careful consultation.

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact